
Sign up to save your podcasts
Or


On this week’s Tech Nation, Moira speaks with Dr. Shana Kelley, President of Bioengineering and Head of Biohub Chicago, about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr. Harry Selker and Dr. Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.
By Tech NationOn this week’s Tech Nation, Moira speaks with Dr. Shana Kelley, President of Bioengineering and Head of Biohub Chicago, about AI-Powered Biology - what is it? And what could it mean for the future of research? Then, Dr. Harry Selker and Dr. Atul Deshpande of Immediate Therapeutics tell us how they’ve come up with a speedy intervention for heart attacks. And, what exactly differentiates the NIH, the FDA, and the CDC? We take a closer look at that, and what they have in common.